Zoetis Inc. expects to close the acquisition of Neogen Corp.’s animal genomics business in the second half of 2026.
Tag Archives Zoetis
Zoetis to acquire Neogen Corp. genomics business
U.S. begins testing bird flu vaccines for poultry after record outbreak
Four vaccines to be tested
Chicago | Reuters — The U.S. government is testing four potential bird flu vaccines for poultry, officials said on Friday, after more than 58 million chickens, turkeys and other birds have died in the nation’s worst outbreak ever. The trials, conducted by the U.S. Department of Agriculture’s (USDA) Agricultural Research Service, are the first step
Zoetis buys livestock data management firm
Performance Beef platform to expand drugmaker's 'precision' production offering
The producer of livestock drugs such as Draxxin, Bovatec and Excede is buying space in the “precision livestock farming” market with a deal for a U.S. livestock data management firm. New Jersey-based Zoetis, which makes drugs and vaccines for the beef and dairy cattle, equine, swine, poultry and sheep sectors as well as cats and
Animal health firm Elanco surges on trading debut
Reuters — Eli Lilly unit Elanco Animal Health’s shares jumped as much as 41 per cent on their stock market debut on Thursday, adding to investor enthusiasm for the fast-growing animal healthcare market. Elanco’s shares opened at $32.25 on the New York Stock Exchange, higher than their IPO price of $24 per share, giving the
Lilly’s Elanco unit expects IPO to raise up to US$1.45 billion
Reuters — Eli Lilly + Co.’s Elanco Animal Health unit expects its initial public offering to raise up to US$1.45 billion, betting on increased appetite among investors for animal health companies. The IPO of 62.9 million shares is expected to be priced between $20-$23 per unit, with the company having a valuation of about $8
Merck to buy Harrisvaccines to boost livestock portfolio
Chicago | Reuters — Merck and Co.’s animal health unit will buy privately-held Harrisvaccines to expand its portfolio of animal vaccines as the U.S. livestock industry seeks new defenses against diseases, the companies said on Thursday. Financial details were not disclosed. The deal, which is expected to close by year-end, follows rival Zoetis’ agreement, announced
Antimicrobial resistance in cattle means big changes coming
An alarming rise in resistance even has drug companies calling for producers to change their ways
Multi-drug resistance to disease-causing bacteria is quickly becoming a complete “game changer” that could cripple the cattle industry’s ability to manage common bovine diseases. “We are really slamming into the end of the antibiotic era,” said Dr. Trisha Dowling, a professor of veterinary pharmacology at the Western College of Veterinary Medicine. “I’ve got 24 different
U.S. developing bird flu vaccine, no distribution plans yet
Chicago | Reuters — The U.S. government is developing a vaccine to protect poultry from new strains of avian flu that have recently killed birds from Arkansas to Washington state. Within two months, scientists at a U.S. Department of Agriculture (USDA) research lab in Georgia will test the vaccine on chickens to see how well
Cyber-Savvy Farmer
